Shareholders Equity (Quarterly) Chart

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 3.769M
March 31, 2026 3.661M
December 31, 2025 7.278M
September 30, 2025 8.902M
June 30, 2025 -2.136M
March 31, 2025 1.439M
December 31, 2024 2.602M
September 30, 2024 3.121M
June 30, 2024 3.433M
March 31, 2024 5.257M
December 31, 2023 4.855M
September 30, 2023 6.994M
Date Value
June 30, 2023 8.098M
March 31, 2023 9.668M
December 31, 2022 11.04M
September 30, 2022 12.60M
June 30, 2022 -12.74M
March 31, 2022 -12.68M
December 31, 2021 -11.75M
September 30, 2021
June 30, 2021
March 31, 2021
December 31, 2020 -11.03M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Veracyte, Inc. 1.388B
Quantum Cyber NV 4.589M
MediciNova, Inc. 37.27M
ADMA Biologics, Inc. 408.21M
ACADIA Pharmaceuticals, Inc. 1.307B

Shareholders Equity (Quarterly) Related Metrics